Bone mineral density 5 to 11 years after metabolic and bariatric surgery in adolescents with severe obesity compared to peers.
adolescent
bariatric surgery
bone mineral density
obesity
Journal
Research square
Titre abrégé: Res Sq
Pays: United States
ID NLM: 101768035
Informations de publication
Date de publication:
21 Sep 2023
21 Sep 2023
Historique:
pubmed:
4
10
2023
medline:
4
10
2023
entrez:
4
10
2023
Statut:
epublish
Résumé
Metabolic and bariatric surgery (MBS) is associated with decreased bone mineral density (BMD) in adults. The long-term impact of MBS during adolescence on BMD is unknown. We report bone health status 5 to 11 years after Roux-en-Y gastric bypass (RYGB) and vertical sleeve gastrectomy (VSG) from the Teen-LABS study cohort. Between 2016 and 2022, BMD was measured by dual energy x-ray absorptiometry (DXA) in 106 young adults who had undergone MBS as adolescents. Volumetric BMD by peripheral quantitative computed tomography was measured on a subset. Ninety-one controls who had not undergone MBS were recruited for comparison. Compared to controls, adjusted mean DXA-BMD of the RYGB (n = 58) and VSG (n = 48) groups were lower at the hip (-10.0% and - 6.3%), femoral neck (-9.6% and - 5.7%) and ultra-distal radius (-7.9% and - 7.0%; all BMD, especially of the hip and femoral neck, was lower in young adults who underwent MBS during adolescence compared to matched peers who had not undergone MBS. BMD Z-scores of the femoral neck decreased with time since MBS but were not associated with BMI change.
Identifiants
pubmed: 37790519
doi: 10.21203/rs.3.rs-3345103/v1
pmc: PMC10543495
pii:
doi:
Types de publication
Preprint
Langues
eng
Déclaration de conflit d'intérêts
Conflicts of interest: HW - Nothing to disclose. TJ – Nothing to disclose. TI – Consultant for Mediflix and receives author royalties from Wolters Kluwer for UpToDate chapter contribution. JR – Receives a donation of drug and placebo for a clinical trial from Boehringer Ingelheim. MM – Intuitive Surgical, Inc (educational honorarium), Intuitive Surgical, Inc (stock ownership – relationship terminated), Lilly USA, LLC (Pediatric Obesity Advisory Board ad hoc member) SS - Consultant for Rhythm Pharmaceuticals CX – Nothing to disclose. HJK - Nothing to disclose.